A potential biomarker for anti-PD-1 immunotherapy

Nature Medicine 24, 123 (2018).
doi:10.1038/nm.4489

Authors: Sangeeta Goswami, Sreyashi Basu & Padmanee Sharma
A recent study identifies an immune cell type known as classical monocytes in the peripheral blood as a potential biomarker for response to anti-PD-1 immune checkpoint therapy in metastatic melanoma.

Source: Nature Medicine - February 7, 2018 Category: General Medicine Authors: Sangeeta Goswami Sreyashi Basu Padmanee Sharma Tags: News and Views Source Type: research